0000899243-17-019539.txt : 20170802
0000899243-17-019539.hdr.sgml : 20170802
20170802163019
ACCESSION NUMBER: 0000899243-17-019539
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170801
FILED AS OF DATE: 20170802
DATE AS OF CHANGE: 20170802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ho Tony W
CENTRAL INDEX KEY: 0001713637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 171000330
MAIL ADDRESS:
STREET 1: CRISPR THERAPEUTICS AG
STREET 2: 610 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-01
0
0001674416
CRISPR Therapeutics AG
CRSP
0001713637
Ho Tony W
C/O CRISPR THERAPEUTICS, INC.
610 MAIN ST.
CAMBRIDGE
MA
02139
0
1
0
0
See Remarks
Restricted Stock Units
2017-08-01
4
A
0
75000
0.00
A
Common Shares
75000
75000
D
Stock Options (Right to Buy)
16.90
2017-08-01
4
A
0
260000
0.00
A
2027-08-01
Common Shares
260000
260000
D
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
The restricted stock units vest in two equal annual installments on 8/1/2018 and 8/1/2019.
This option was granted on August 1, 2017 with respect to 260,000 Common Shares of which 25% shall vest on 8/1/2018 and the remaining 75% shall vest in 36 equal monthly installments on the final day of each succeeding calendar month.
Executive Vice President, Head of Research & Development
/s/ James R. Kasinger, attorney-in-fact
2017-08-02